Literature DB >> 22273572

Comparative hepatitis A seroepidemiology in 10 European countries.

S Kurkela1, R Pebody, G Kafatos, N Andrews, C Barbara, B Bruzzone, D Butur, S Caplinskas, I Davidkin, A Hatzakis, W Hellenbrand, L M Hesketh, A Nardone, V Nemecek, A Pistol, Z Sobotová, R Vranckx, C G Anastassopoulou.   

Abstract

The WHO recommends hepatitis A virus (HAV) immunization according to level of transmission and disease burden. We aimed to identify susceptible age groups by standardized serosurveys to inform HAV vaccination policy in participating countries: Belgium, Czech Republic, England, Finland, Germany, Italy, Lithuania, Malta, Romania, and Slovakia. Each country tested national serum banks (n = 1854-6748), collected during 1996-2004, for anti-HAV antibodies. Local laboratory results were standardized to common units. Forty-one per cent of those aged <30 years and 6% of those aged ≥30 years were susceptible to HAV in Romania; compared to 70-94% and 26-71%, respectively, elsewhere. Romania reported high HAV incidence in children and young adults. Other countries reported HAV disease primarily in older risk groups. The results suggest low level of HAV transmission in most of Europe. Romania, however, appeared as an area with intermediate transmission. Vaccination of risk groups in countries with high susceptibility of young and middle-aged adults needs to be continued.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22273572      PMCID: PMC9152342          DOI: 10.1017/S0950268812000015

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  40 in total

1.  Hepatitis A vaccines.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2000-02-04

2.  Hepatitis A outbreak amongst intravenous amphetamine abusers in Finland.

Authors:  T Leino; P Leinikki; T Hyypiä; M Ristola; J Suni; J Sutinen; A Holopainen; O Haikala; M Valle; T Rostila
Journal:  Scand J Infect Dis       Date:  1997

3.  Current outbreak of hepatitis A in Bulgaria, 2006.

Authors:  M Kojouharova
Journal:  Euro Surveill       Date:  2006-10-05

Review 4.  Hepatitis A vaccines.

Authors:  Hans Dieter Nothdurft
Journal:  Expert Rev Vaccines       Date:  2008-07       Impact factor: 5.217

5.  An outbreak of hepatitis A in young adults in central Italy.

Authors:  T Stroffolini; W Biagini; L Lorenzoni; G P Palazzesi; M Divizia; R Frongillo
Journal:  Eur J Epidemiol       Date:  1990-06       Impact factor: 8.082

6.  An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users.

Authors:  Enea Spada; Domenico Genovese; Maria Elena Tosti; Andrea Mariano; Marco Cuccuini; Laura Proietti; Cinzia Di Giuli; Alessandro Lavagna; Giuseppe Edoardo Crapa; Graziella Morace; Stefania Taffon; Alfonso Mele; Giovanni Rezza; Maria Rapicetta
Journal:  J Hepatol       Date:  2005-07-11       Impact factor: 25.083

7.  Foodborne outbreaks of hepatitis A in a low endemic country: an emerging problem?

Authors:  R G Pebody; T Leino; P Ruutu; L Kinnunen; I Davidkin; H Nohynek; P Leinikki
Journal:  Epidemiol Infect       Date:  1998-02       Impact factor: 2.451

8.  Age-specific antibody prevalence to hepatitis A in England: implications for disease control.

Authors:  N J Gay; P Morgan-Capner; J Wright; C P Farrington; E Miller
Journal:  Epidemiol Infect       Date:  1994-08       Impact factor: 2.451

9.  An outbreak of hepatitis A among homosexuals linked to a family outbreak.

Authors:  K Stene-Johansen; P A Jenum; T Hoel; H Blystad; H Sunde; K Skaug
Journal:  Epidemiol Infect       Date:  2002-08       Impact factor: 2.451

10.  Hepatitis A epidemic in the elderly.

Authors:  Geri R Brown; Kim Persley
Journal:  South Med J       Date:  2002-08       Impact factor: 0.954

View more
  11 in total

1.  Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany.

Authors:  A Krumbholz; A Neubert; H Girschick; H I Huppertz; P Kaiser; J Liese; A Streng; T Niehues; J Peters; A Sauerbrey; H Schroten; T Tenenbaum; S Wirth; A Sauerbrei
Journal:  Med Microbiol Immunol       Date:  2013-06-29       Impact factor: 3.402

2.  Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?

Authors:  G Kafatos; N Andrews; K J McConway; C Anastassopoulou; C Barbara; F De Ory; K Johansen; J Mossong; K Prosenc; R Vranckx; A Nardone; R Pebody; P Farrington
Journal:  Epidemiol Infect       Date:  2014-11-25       Impact factor: 4.434

3.  HAV Immunity in Iranian Medical Students.

Authors:  Seyyed Javad Hosseini Shokouh; Alireza Dadashi; Mohamad Abiri; Iraj Zohrevand; Ahad Eshraghian; Alireza Khoshdel; Behnam Heidari; Shayan Khoshkish
Journal:  Hepat Mon       Date:  2015-03-31       Impact factor: 0.660

4.  Serosurveillance of hepatitis A in a region which adopted the universal mass vaccination.

Authors:  Maria Filomena Gallone; Francesco Desiante; Maria Serena Gallone; Giovanna Barbuti; Silvio Tafuri; Cinzia Germinario
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

5.  Declining seroprevalence of hepatitis A in Vojvodina, Serbia.

Authors:  Snežana Medić; Cleo Anastassopoulou; Vesna Milošević; Nataša Dragnić; Smiljana Rajčević; Mioljub Ristić; Vladimir Petrović
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

6.  The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: a comparative analysis with hepatitis A virus seroprevalence.

Authors:  G S A Smit; S Abrams; P Dorny; N Speybroeck; B Devleesschauwer; V Hutse; H Jansens; H Theeten; P Beutels; N Hens
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

7.  Oral fluid testing facilitates understanding of hepatitis A virus household transmission.

Authors:  Becky Haywood; Richard S Tedder; Kazim Beebeejaun; Koye Balogun; Sema Mandal; Nick Andrews; Siew Lin Ngui
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

8.  Detection and control of an ongoing international outbreak of hepatitis A among the Irish Traveller community beginning September 2020.

Authors:  David Kelly; Colette O'Hare; Paul McKeown; Fiona Cianci; Sarah Doyle
Journal:  Epidemiol Infect       Date:  2022-02-16       Impact factor: 2.451

Review 9.  A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region.

Authors:  Selim Badur; Serdar Öztürk; Alev Ozakay; Mansour Khalaf; Debasish Saha; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2021-07-02       Impact factor: 4.526

10.  Evidence of hepatitis A virus person-to-person transmission in household outbreaks.

Authors:  Lyana Rodrigues Lima; Adilson José De Almeida; Renata dos Santos Tourinho; Bárbara Hasselmann; Lia Laura Lewis Ximenez; Vanessa Salete De Paula
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.